FDA Inspection 1079880 — Grifols Diagnostic Solutions, Inc.

Grifols Diagnostic Solutions, Inc. — FEI 1000124057

The FDA completed an inspection of Grifols Diagnostic Solutions, Inc. on February 15, 2019 in Emeryville, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 15, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Emeryville, CA (United States)